Skip to main content
Fig. 3 | BMC Complementary and Alternative Medicine

Fig. 3

From: Effects of a combination treatment of KD5040 and L-dopa in a mouse model of Parkinson’s disease

Fig. 3

Effects of combination treatment on days 1 (a), 3 (b), 5 (c), and 7 (d) after first treatment with KD5040 based on the rearing test. The number of rearing behaviors in both l -dopa groups (LL and ML) significantly increased relative to the MPTP group, which increased further after co-administration with KD5040. C: control, M: MPTP, K: KD5040, LL: low dose of l -dopa (5 mg/kg), ML: medium dose of l -dopa (10 mg/kg). ***p < 0.001 compared to control, ### p < 0.001 and ##p < 0.01 compared to MPTP, and ††† p < 0.001 and †† p < 0.01, compared to each dose of l -dopa

Back to article page
\